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tured and an ex vivo cartilage graft is produced. Subjecting these 
chondrocytes to either selenium (SEL), Nivalenol (NIV) or in com- 
bination during the growth of the graft has been found to alter 
the morphology of the cartilage graft. In addition, the quantity of 
the large aggregating proteoglycan, was significantly reduced in a 
dose dependent manner in the presence of Nivalenol. This study 
aimed to examine the composition of aggrecan from cartilage 
grafts grown in the presence of NIV or SEL alone, or in combi- 
nation to better understand cellular and molecular mechanisms 
underlying the pathogenesis of KBD. 
Methods: Chondrocytes (7 day old bovine cartilage) were 
seeded at high density in MilliCell filter inserts (12mm diam- 
eter; Millipore, MA). Cultures were maintained for 4 weeks in 
DMEM supplemented with 20% heat-inactivated FBS, ascorbate 
(1001~g/ml) and TGFI~2 (5ng/ml) or additionally supplemented 
with either SEL, NIV or both at varying concentrations. Media was 
refreshed thrice weekly and later analysed. At 4 weeks the carti- 
lage grafts were harvested, weighed and extracted in 4M guanid- 
ium chloride containing an inhibitor cocktail for biochemical anal- 
ysis of matrix molecules. Residues were digested with papain. 
Glycosaminoglycan concentration was determined in all samples 
and extracts. Aggrecan and GAG composition was determined 
using Western blotting. 
Results: The total GAG synthesised in a 4week period was sub- 
stantially reduced in chondrocytes cultured in the presence of NIV 
in a dose dependant manner, and to a lesser extent in those cul- 
tures exposed to the highest dose of SEL. However, the amount 
of GAG released into the media remained fairly constant within 
the treatment groups, but a marked reduction was apparent in 
the guanidine extracts of the cartilage grafts. Western blot anal- 
ysis with a series of antibodies on guanidine extracted aggre- 
can showed no substantial changes in the core protein molecular 
weights however analysis demonstrated that KS was reduced in 
NIV treated cultures. Results also indicated that NIV treated cul- 
tures appeared to contain less CS substitutions on the aggrecan 
core protein. 
Discussion: The data on GAG concentrations indicates that 
there is an inability of the GAG to remain within the cartilage 
grafts extracellular matrix.when treated with NIV. Western blot 
analysis indicates minor changes in the composition of the ag- 
grecan in relation to protein core length and CS/KS side chain 
substitutions or length. Further work will investigate the propor- 
tion of aggrecan able to form high molecular weight aggregates, 
the metabolism of link protein and hyaluronan. 
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Signaling by members of the Bone Morphogenetic Protein fam- 
ily plays a critical role in cartilage development and differentiation 
as well as maintenance during adulthood. Recently, this poten- 
tial involvement of BMPs in the maintenance and repair of dam- 
aged adult articular cartilage have initiated an interest in the role 
of BMP signaling and the involved signaling pathways in the adult 
tissue. In this study, we identified Hgs as a novel Smad5 interactor 
using a cDNA expression library constructed from human adult 
cartilage. This interaction was confirmed by coimmunoprecipita- 
tion experiments and was shown to be independent of ligand (i.e. 
BMP) stimulation. Overexpression of Hgs resulted in an attenua- 
tion of BMP-dependent ranscriptional responses suggesting that 
Hgs acts as an inhibitor of BMP signaling. Of note, osteoarthritic 
chondrocytes which have been suggested previously to show in- 
creased reactivity to BMP-stimulation showed less expression of 
Hgs. Thus, it is tempting to speculate that both might be related to 
each other given the suppressive effect of BMP-signaling of Hgs 
shown in this study. 
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Aim of Study: Although the OPG/RANKL ratio is considered a 
key element in the regulation of bone metabolism, there is lit- 
tle data on these factor levels in human osteoarthritic (OA) sub- 
chondral bone. We previously reported that OA patients can be 
discriminated into two subgroups identified by the endogenous 
(low or high) production of PGE2 by osteoblasts that otherwise 
show no different phenotypic features. We investigated the rela- 
tionship between the level of expression of OPG and RANKL in 
both human normal and OA subchondral bone osteoblast sub- 
groups. Furthermore, we analysed the effect of bone remodeling 
factors on OPG and RANKL expression levels as well as on the 
mineralization process. 
Methods: Gene expression was determined using real-time 
PCR. Gene regulation and the mineralization process were mon- 
itored on OA osteoblasts following treatment with vitamin D3 (50 
n M), TG F-I~I (5 ng/m I), I L-1 I~ (100 pg/ml), TN F-~ (5 ng/m I), PG E2 
(500 nM), or PTH (100 nM). 
Results: Human osteoblasts demonstrated a much higher level 
of OPG expression than RANKL. OA expressed less OPG than 
normal; this was more marked in the low OA cells. Compared to 
normal, RANKL levels were increased in low OA and decreased 
in high OA. Correlation analysis revealed that in low OA for any 
given level of OPG expression, the corresponding level of RANKL 
was about 7.5 times greater than in normal. The OPG/RANKL ra- 
tio was diminished in low OA compared to normal or high OA 
(p<0.02 and p<0.03), and markedly increased in high OA com- 
pared to normal. In low OA cells, both vitamin D3 and TGF-I~I 
significantly reduced the OPG/RANKL ratio, IL-11~ had no modi- 
fication, and the ratio markedly increased in response to TNF-~ 
(335-fold), and to a lesser extent to PTH and PGE2 (30- and 7- 
fold). Mineralization patterns generally agree with OPG/RANKL 
levels. 
Conclusion: Data revealed that OPG and RANKL expression 
levels, and consequently the OPG/RANKL ratio, differed accord- 
ing to human OA subchondral bone osteoblast classification. The 
OPG/RANKL balance is disturbed, being decreased in the low 
OA osteoblasts thus favoring RANKL, and increased in the high 
OA osteoblasts. This suggests that the low OA osteoblasts are 
enriched in factors promoting bone resorption, and that the high 
OA cells have reached a more advanced stage in the progression 
of the disease with reduced resorptive properties. The latter may 
be due to a flare in disease activity, in which factors including 
TNF-~ and PGE2 are highly upregulated, thus promoting bone 
deposition. 
